Literature DB >> 21236347

Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine.

Pamela J Voulalas1, John Schetz, Ashiwel S Undieh.   

Abstract

We investigated the subcellular distribution of dopamine D(1), D(2) and D(5) receptor subtypes in rat frontal cortex, and examined whether psychostimulant-induced elevation of synaptic dopamine could alter the receptor distribution. Differential detergent solubilization and density gradient centrifugation were used to separate various subcellular fractions, followed by semi-quantitative determination of the relative abundance of specific receptor proteins in each fraction. D(1) receptors were predominantly localized to detergent-resistant membranes, and a portion of these receptors also floated on sucrose gradients. These properties are characteristic of proteins found in lipid rafts and caveolae. D(2) receptors exhibited variable distribution between cytoplasmic, detergent-soluble and detergent-resistant membrane fractions, yet were not present in buoyant membranes. Most D(5) receptor immunoreactivity was distributed into the cytoplasmic fraction, failing to sediment at forces up to 300,000g, while the remainder was localized to detergent-soluble membranes in cortex. D(5) receptors were undetectable in detergent-resistant fractions or raft-like subdomains. Following daily cocaine administration for seven days, a significant portion of D(1) receptors translocated from detergent-resistant membranes to detergent-soluble membranes and the cytoplasmic fraction. The distributions of D(5) and D(2) receptor subtypes were not significantly altered by cocaine treatment. These data imply that D(5) receptors are predominantly cytoplasmic, D(2) receptors are diffusely distributed within the cell, whereas D(1) receptors are mostly localized to lipid rafts within the rat frontal cortex. Dopamine receptor subtype localization is susceptible to modulation by pharmacological manipulations that elevate synaptic dopamine, however the functional implications of such drug-induced receptor warrant further investigation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236347      PMCID: PMC3055788          DOI: 10.1016/j.mcn.2011.01.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  67 in total

Review 1.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

2.  Cellular distribution of the rat D1B receptor in central nervous system using anti-receptor antisera.

Authors:  M A Ariano; J Wang; K L Noblett; E R Larson; D R Sibley
Journal:  Brain Res       Date:  1997-01-23       Impact factor: 3.252

Review 3.  Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement.

Authors:  S M Anderson; R C Pierce
Journal:  Pharmacol Ther       Date:  2005-02-26       Impact factor: 12.310

4.  In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons.

Authors:  L B Jones; G D Stanwood; B S Reinoso; R A Washington; H Y Wang; E Friedman; P Levitt
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

5.  Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.

Authors:  You He; Lei-Ping Yu; Guo-Zhang Jin
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

6.  Functional role of lipid raft microdomains in cyclic nucleotide-gated channel activation.

Authors:  James D Brady; Thomas C Rich; Xuan Le; Kimberlee Stafford; Cedar J Fowler; Leatha Lynch; Jeffrey W Karpen; R Lane Brown; Jeffrey R Martens
Journal:  Mol Pharmacol       Date:  2004-03       Impact factor: 4.436

7.  Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.

Authors:  Samuel P Lee; Christopher H So; Asim J Rashid; George Varghese; Regina Cheng; A José Lança; Brian F O'Dowd; Susan R George
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

8.  Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.

Authors:  Amandine Berthet; Grégory Porras; Evelyne Doudnikoff; Holger Stark; Martine Cador; Erwan Bezard; Bertrand Bloch
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

9.  Intact transmembrane isoforms of the neural cell adhesion molecule are released from the plasma membrane.

Authors:  M Olsen; L Krog; K Edvardsen; L T Skovgaard; E Bock
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

10.  Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes.

Authors:  R G Vickery; M von Zastrow
Journal:  J Cell Biol       Date:  1999-01-11       Impact factor: 10.539

View more
  13 in total

Review 1.  Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.

Authors:  Joanne J Liu; Adrienne Hezghia; Saame Raza Shaikh; Joshua F Cenido; Ruth E Stark; J John Mann; M Elizabeth Sublette
Journal:  Neuropsychopharmacology       Date:  2018-06-28       Impact factor: 7.853

2.  In vivo reduction of striatal D1R by RNA interference alters expression of D1R signaling-related proteins and enhances methamphetamine addiction in male rats.

Authors:  Alison D Kreisler; Michael J Terranova; Sucharita S Somkuwar; Dvijen C Purohit; Shanshan Wang; Brian P Head; Chitra D Mandyam
Journal:  Brain Struct Funct       Date:  2020-04-03       Impact factor: 3.270

3.  Methamphetamine reduces expression of caveolin-1 in the dorsal striatum: Implication for dysregulation of neuronal function.

Authors:  Sucharita S Somkuwar; McKenzie J Fannon; Brian P Head; Chitra D Mandyam
Journal:  Neuroscience       Date:  2016-04-30       Impact factor: 3.590

4.  Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion.

Authors:  Pamela J Voulalas; Yadong Ji; Li Jiang; Jamila Asgar; Jin Y Ro; Radi Masri
Journal:  Neuroscience       Date:  2016-12-05       Impact factor: 3.590

5.  Role for Rab10 in Methamphetamine-Induced Behavior.

Authors:  Scott M Vanderwerf; David C Buck; Phillip A Wilmarth; Leila M Sears; Larry L David; David B Morton; Kim A Neve
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

6.  Spatial Working Memory in Male Rats: Pre-Experience and Task Dependent Roles of Dopamine D1- and D2-Like Receptors.

Authors:  Mekite Bezu; Jovana Maliković; Martina Kristofova; Ephrem Engidawork; Harald Höger; Gert Lubec; Volker Korz
Journal:  Front Behav Neurosci       Date:  2017-10-13       Impact factor: 3.558

7.  Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV.

Authors:  Stephanie M Matt; Emily A Nickoloff-Bybel; Yi Rong; Kaitlyn Runner; Hannah Johnson; Margaret H O'Connor; Elias K Haddad; Peter J Gaskill
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

8.  Caveolin-1 Expression in the Dorsal Striatum Drives Methamphetamine Addiction-Like Behavior.

Authors:  Yosef Avchalumov; Alison D Kreisler; Wulfran Trenet; Mahasweta Nayak; Brian P Head; Juan C Piña-Crespo; Chitra D Mandyam
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 6.208

9.  Segregation and crosstalk of D1 receptor-mediated activation of ERK in striatal medium spiny neurons upon acute administration of psychostimulants.

Authors:  Omar Gutierrez-Arenas; Olivia Eriksson; Jeanette Hellgren Kotaleski
Journal:  PLoS Comput Biol       Date:  2014-01-30       Impact factor: 4.475

10.  The influence of different cellular environments on PET radioligand binding: an application to D2/3-dopamine receptor imaging.

Authors:  Darren R Quelch; Sarah L Withey; David J Nutt; Robin J Tyacke; Christine A Parker
Journal:  Neuropharmacology       Date:  2014-06-06       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.